Identity
- Security key
- 16955
- Ticker
- IGC
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2006-04-13
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- IGC
Detail
Enriched 2026-08-14 20:47
- Market cap
- $29,838,288
- Shares outstanding (class)
- 100,091,317
- Shares outstanding (weighted)
- 104,366,170
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 70
- Location
- POTOMAC, MD
- Homepage
- https://www.igcinc.us
- Description
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.